QuidelOrtho To Participate In Upcoming Investor Conferences

Rhea-AI Summary

QuidelOrtho (Nasdaq: QDEL) announced that management will participate in two investor conferences in early December 2025: the Evercore ISI 8th Annual Healthcare Conference on December 2, 2025 with a fireside chat at 10:00 a.m. ET / 7:00 a.m. PT, and the Citi Global Healthcare Conference on December 3, 2025 with a fireside chat at 1:00 p.m. ET / 10:00 a.m. PT.

Investors can access the live webcasts and replays in the Events & Presentations section of QuidelOrtho's Investor Relations site at https://ir.quidelortho.com/.

News Market Reaction – QDEL

+9.16%

+9.16% Session close to close

In the Nov 24 session, QDEL gained 9.16%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team will participate in two upcoming investor conferences:

• Evercore ISI 8th Annual Healthcare Conference, Tuesday, December 2, 2025
  Members of QuidelOrtho's management team are scheduled to participate in a fireside chat at 10:00 a.m. ET / 7:00 a.m. PT.
  
  
• Citi Global Healthcare Conference, Wednesday, December 3, 2025
  Members of QuidelOrtho's management team are scheduled to participate in a fireside chat at 1:00 p.m. ET / 10:00 a.m. PT.

Interested parties can access the live webcast and replay in the "Events & Presentations" section of the "Investor Relations" page of QuidelOrtho's website at https://ir.quidelortho.com/.

QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.

About QuidelOrtho Corporation

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.

Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@QuidelOrtho.com

Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-participate-in-upcoming-investor-conferences-302624120.html

SOURCE QuidelOrtho Corporation

FAQ

When will QuidelOrtho (QDEL) present at the Evercore ISI Healthcare Conference?

QuidelOrtho management will participate in a fireside chat at the Evercore ISI Healthcare Conference on December 2, 2025 at 10:00 a.m. ET.

What time is QuidelOrtho's (QDEL) Citi Global Healthcare Conference fireside chat on December 3, 2025?

The fireside chat is scheduled for December 3, 2025 at 1:00 p.m. ET.

Where can investors watch the QuidelOrtho (QDEL) conference webcasts and replays?

Live webcasts and replays are available in the Events & Presentations section of QuidelOrtho's Investor Relations site at https://ir.quidelortho.com/.

Which executive team will represent QuidelOrtho (QDEL) at the December 2025 investor conferences?

The announcement states that members of QuidelOrtho's management team will participate; specific presenters were not named.

How can I get reminders or follow QuidelOrtho (QDEL) updates about the December 2025 presentations?

Visit QuidelOrtho's website, follow the company on LinkedIn, Facebook, and X, or check the Investor Relations Events & Presentations page for updates.